Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Regulus Therapeutics Inc have a median target of 7.50, with a high estimate of 28.00 and a low estimate of 3.00. The median estimate represents a 380.77% increase from the last price of 1.56.
High | 1,694.9% | 28.00 |
Med | 380.8% | 7.50 |
Low | 92.3% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 19, 2025.
Average growth rate | +11.34% |
Average growth rate | +36.04% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -13.39% |
More ▼